Upper control limit of reactive oxygen species in follicular fluid beyond which viable embryo formation is not favorable

Other OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study identified an upper reactive oxygen species threshold of approximately 107 cps/400 microliters in follicular fluid above which viable embryo formation and pregnancy rates are unfavorable.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Though the role of reactive oxygen species (ROS) in female infertility has been a subject of rigorous research worldwide, there is inadequate information on the cut-off value of ROS in the oocyte microenvironment beyond which ART outcome may be adversely affected. An upper ROS level in follicular fluid (FF) samples of women undergoing IVF beyond which good quality embryo formation is unlikely, is established. ROS, lipid peroxidation and total antioxidant capacity were estimated. The upper cut-off ROS level beyond which viable embryo formation is not favorable was found to be approximately 107 cps/400 microl FF. This level, determined in women with tubal factor infertility, was further validated in women with endometriosis and PCOS and correlated with fertilization and pregnancy rate and embryo quality. Summarizing, a threshold level in FF has been established for the first time beyond which ROS may be considered toxic for viable embryo formation and pregnancy outcome.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Embryo, Mammalian Follicular Fluid Infertility, Female Reactive Oxygen Species Adult Adult DNA Fragmentation DNA Fragmentation Embryo, Mammalian Embryo, Mammalian Endometriosis Endometriosis Endometriosis Female Female Fertilization in Vitro Fertilization in Vitro Follicular Fluid Follicular Fluid Humans

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
pubmed
last seen: 2026-10-08T21:07:31.877465+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine